Catechin relieves hypoxia/reoxygenation-induced myocardial cell apoptosis via down-regulating lncRNA MIAT

J Cell Mol Med. 2020 Feb;24(3):2356-2368. doi: 10.1111/jcmm.14919. Epub 2020 Jan 19.

Abstract

Background: Catechin protects heart from myocardial ischaemia/reperfusion (MI/R) injury. However, whether catechin inhibits H/R-induced myocardial cell apoptosis is largely unknown.

Objective: This study aims to investigate the underlying mechanism of catechin in inhibiting the apoptosis of H/R-induced myocardial cells.

Methods: LncRNA MIAT expression was detected by qRT-PCR. Cell viability of H9C2 cells was detected using CCK-8 assay. The apoptosis of H9C2 cells was detected by flow cytometry. The interaction between CREB and MIAT promoter regions was confirmed by dual-luciferase reporter gene assay and ChIP assay.

Results: In MI/R rats, catechin improved heart function and down-regulated lncRNA MIAT expression in myocardial tissue. In H/R-induced H9C2 cells, catechin protected against cell apoptosis, and lncRNA MIAT overexpression attenuated this protective effect of catechin. We confirmed that transcription factor CREB could bind to MIAT promoter region, and catechin suppressed lncRNA MIAT expression through up-regulating CREB. Catechin improved mitochondrial function and relieved apoptosis through promoting Akt/Gsk-3β activation. In addition, MIAT inhibited Akt/Gsk-3β activation and promoted cell apoptosis in H/R-induced H9C2 cells. Finally, we found catechin promoted Akt/Gsk-3β activation through inhibiting MIAT expression in H/R-induced H9C2 cells.

Conclusion: Catechin relieved H/R-induced myocardial cell apoptosis through regulating CREB/lncRNA MIAT/Akt/Gsk-3β pathway.

Keywords: Akt/Gsk-3β; catechin; hypoxia/reoxygenation; lncRNA MIAT; myocardial cell apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Apoptosis / genetics
  • Catechin / pharmacology*
  • Cell Line
  • Cell Survival / drug effects
  • Cell Survival / genetics
  • Down-Regulation / drug effects*
  • Down-Regulation / genetics
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / genetics
  • Glycogen Synthase Kinase 3 beta / genetics
  • Hypoxia / drug therapy*
  • Hypoxia / genetics
  • Male
  • Myocardial Reperfusion Injury / drug therapy
  • Myocardial Reperfusion Injury / genetics
  • Myocytes, Cardiac / drug effects*
  • Phosphatidylinositol 3-Kinases / genetics
  • Promoter Regions, Genetic / drug effects
  • Promoter Regions, Genetic / genetics
  • Proto-Oncogene Proteins c-akt / genetics
  • RNA, Long Noncoding / genetics*
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • Up-Regulation / drug effects
  • Up-Regulation / genetics

Substances

  • Miat long non-coding RNA
  • RNA, Long Noncoding
  • Catechin
  • Glycogen Synthase Kinase 3 beta
  • Proto-Oncogene Proteins c-akt